Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)
Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) represented a move of -0.22 percent or $0 per share and closed its previous day trading session at $4.58. 1.52 Million Shares were traded in the last trading session with an Average Volume of 983.13 Million Shares. The stock currently has a Market Capitalization of 248.33 Million.
Foamix Pharmaceuticals Ltd. is a specialty pharmaceutical company. It develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. The Company’s lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. It has operations primarily in the United States, Germany, and Israel. Foamix Pharmaceuticals Ltd. is headquartered in Rehovot, Israel.
The stock traded between $4.12 and $7.60 over 1-Year time period showing its price to sales ratio of 65.35. Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a INCREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-14.23 and 200-Day Simple Moving Average of $-16.23. Its Price to Free Cash Flow is 0 and Price to Book of 4.2.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) reported its Actual EPS of $-0.38/share. The analysts offering Earnings Estimates for the company were believing that Foamix Pharmaceuticals Ltd. could bring EPS of $-0.47/share. The difference between Actual EPS and Estimated EPS was 0.09 Percent. Thus showing an Earnings Surprise of 19.1 Percent.
MPLX LP (NYSE:MPLX)
In the last trading session, MPLX LP (NYSE:MPLX) added its value by -0.18% closing at the price of $33.96. The stock currently has market capitalization of 28.19 Billion, with average volume of 1.58 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently MPLX LP (NYSE:MPLX) is showing beta of 1.28. This particular value of beta suggests that MPLX LP (NYSE:MPLX) has historically moved 128% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for MPLX LP (NYSE:MPLX) is at $1.76.
The stock currently has RSI of 46.06. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
MPLX LP is a fee-based limited partnership formed to own, operate, develop and acquire crude oil, refined product and other hydrocarbon-based product pipelines and other midstream assets. The Company’s assets consist of a network of common carrier crude oil and product pipeline systems and associated storage assets in the Midwest and Gulf Coast regions of the United States. MPLX LP is based in Findlay, Ohio.
MPLX LP (NYSE:MPLX) topped its 52-week high price of $39.38 on 01/16/18 and 52-Week Low Price of $31.60 on 03/15/18. The Stock currently has P/E (price to earnings ttm) of 19.35 and Weekly volatility of 2.85% and monthly volatility of 2.86% respectively.